A new course at Harvard Chan School focuses on the history of public health, highlighting longstanding issues such as vaccine hesitancy, how life expectancy has been measured and used, tensions in the relationship between the fields of public…
At the 16th Kolokotrones Symposium, experts discussed the importance of including pregnant people when testing vaccines and drugs, the challenges of collecting data for that population, and research methods that could help fill the data gap.
RSV, COVID-19, and flu—the season’s most worrisome respiratory viruses—were the focus of an hour-long Instagram Live conversation on December 14 between top vaccinologists Kizzmekia Corbett-Helaire and Barney Graham.
At the 175th Cutter Lecture on Preventive Medicine at Harvard Chan School, Rochelle Walensky shared major challenges she faced and lessons learned during her tenure as director of the Centers for Disease Control and Prevention.
With COVID now added to the annual mix of viruses that typically circulate every year, including influenza, respiratory syncytial virus (RSV), and other respiratory viruses, “sick season” is likely to be worse—and longer—going forward.
With coronavirus levels in Boston-area wastewater increasing ahead of the holiday season, people should get the latest COVID-19 vaccine and use rapid antigen tests if they feel sick, according to experts.
As North Korea reopens its international borders after two years of near-total closure, ensuring that children there get access to life-saving vaccines should be a public health priority, according to Hyung Joon Kim, a DrPH student at Harvard…
Vaccinologist Kizzmekia Corbett-Helaire—who played a key role in developing the mRNA-based platform that enabled the creation of COVID-19 vaccines that have protected millions—answers questions about COVID-19 vaccines and boosters, as well as other vaccines.
Monitoring wastewater for signs of the influenza virus and respiratory syncytial virus (RSV) could help public officials better respond to upcoming surges this fall and winter, according to Harvard Chan School's Bill Hanage.
Launched in 2021, CAUSALab brings together 14 epidemiology faculty members across multiple universities to collaborate on applying causal inference methods to compare the effectiveness and safety of health and policy interventions in a broad range of areas.